BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases - PubMed (original) (raw)

Review

doi: 10.1038/nrn3505. Epub 2013 May 15.

Affiliations

Review

BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

Bai Lu et al. Nat Rev Neurosci. 2013 Jun.

Abstract

Increasing evidence suggests that synaptic dysfunction is a key pathophysiological hallmark in neurodegenerative disorders, including Alzheimer's disease. Understanding the role of brain-derived neurotrophic factor (BDNF) in synaptic plasticity and synaptogenesis, the impact of the BDNF Val66Met polymorphism in Alzheimer's disease-relevant endophenotypes - including episodic memory and hippocampal volume - and the technological progress in measuring synaptic changes in humans all pave the way for a 'synaptic repair' therapy for neurodegenerative diseases that targets pathophysiology rather than pathogenesis. This article reviews the key issues in translating BDNF biology into synaptic repair therapies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurology. 2005 May 10;64(9):1553-62 - PubMed
    1. Development. 2003 Apr;130(7):1267-80 - PubMed
    1. Neuroscience. 2006 Oct 13;142(2):505-14 - PubMed
    1. Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):73-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5104-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources